HomeNewsIndia586 COVID-19 hospitals with 1 lakh isolation beds, over 11K ICU beds across country: Health Ministry

586 COVID-19 hospitals with 1 lakh isolation beds, over 11K ICU beds across country: Health Ministry

Addressing a press briefing, Health Ministry's Joint Secretary Lav Agarwal said the government has taken early preemptive action to identify COVID-19 hotspots in the country.

April 11, 2020 / 19:14 IST
Representative image

A total of 586 hospitals in the country have been marked as dedicated COVID-19 hospitals with capacity of over one lakh isolation beds and 11,500 ICU beds reserved for coronavirus patients, the Union Health Ministry said on Saturday.

Addressing a press briefing, Health Ministry's Joint Secretary Lav Agarwal said the government has taken early preemptive action to identify COVID-19 hotspots in the country.

In the absence of a lockdown and other containment measures, there would have been over 8.2 lakh coronavirus cases in the country till April 15, he said.

According to the Health Ministry, 1,035 fresh COVID-19 cases and 40 deaths due to the disease were reported in the last 24 hours across the country, taking the total number of cases to 7,447 and deaths to 239 nationwide.

Agarwal said, "586 dedicated COVID-19 hospitals have been earmarked at the state and centre level. One lakh isolation beds and 11,500 ICU beds have been reserved for coronavirus patients across country. This figure is being augmented every day, based on the evolving situation."

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

He further said, "We had done an analysis on the rate of growth in cases. We observed Janta curfew on March 22 and went for lockdown from March 25. According to statistical analysis, in the absence of lockdown and other containment measures, there would have been 41 per cent increase and 8.2 lakh coronavirus cases by April 15," Agarwal said.

He asserted that measures like social distancing, lockdown and other containment efforts are important in fighting the battle against coronavirus.

"The response of Government of India has been preemptive, proactive and to the extent of being over-prepared and through our graded approach, we have aligned our response with the evolving situation. Ministry of AYUSH has prepared a set of guidelines on respiratory health and to boost immunity. Districts have been asked to incorporate this in district-level contingency plan as well," he said.

Agarwal also asserted that there is no shortage in the country of anti-malarial drug hydroxychloroquine, cited by many as a viable therapeutic solution to counter the coronavirus infection.

Responding to a question, a senior official of the Indian Council of Medical Research (ICMR) said, "Five lakh antibody testing kits ordered by ICMR have not been received yet".

The ICMR official said over 1.7 lakh samples have been tested in country so far for COVID-19, of which 16,564 samples were tested on Friday.

Follow our full coverage of the coronavirus pandemic here.

PTI
first published: Apr 11, 2020 07:00 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347